Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Acta Ophthalmologica
|
May 4, 2013
Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study
Athanasios Bezatis, Georg Spital, Fabian Höhn, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
December 16, 2014
Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial
Thomas C Kreutzer, Armin Wolf, Martin Dirisamer, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
May 3, 2017
Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes
Lars-Olof Hattenbach, Christina Springer-Wanner, Hans Hoerauf, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
June 10, 2017
[Intraoperative Optical Coherence Tomography in Vitreoretinal Surgery: Clinical Experiences and Future Developments]
Mathias M Maier, Ali Nasseri, Carsten Framme, et al.
Current Eye Research
|
November 1, 2019
Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: <i>Post-hoc</i> Analysis from the COMRADE Trials
Amelie Pielen, Nicolas Feltgen, Lars-Olof Hattenbach, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
December 16, 2014
Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Albert J Augustin, Frank G Holz, Christos Haritoglou, et al.
Investigative Ophthalmology & Visual Science
|
February 3, 2018
Sphingosine Kinase 2 Modulates Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy
Jeanette Eresch, Martin Stumpf, Alexander Koch, et al.
Acta Ophthalmologica
|
June 2, 2018
Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study
Nicolas Feltgen, Lars-Olof Hattenbach, Thomas Bertelmann, et al.
Acta Ophthalmologica
|
March 3, 2017
Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B)
Lars-Olof Hattenbach, Nicolas Feltgen, Thomas Bertelmann, et al.
American Journal of Ophthalmology
|
July 13, 2016
Reply
Hans Hoerauf, Nicolas Feltgen, Claudia Weiss, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Acta Ophthalmologica
|
May 4, 2013
Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study
Athanasios Bezatis, Georg Spital, Fabian Höhn, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
December 16, 2014
Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial
Thomas C Kreutzer, Armin Wolf, Martin Dirisamer, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
May 3, 2017
Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes
Lars-Olof Hattenbach, Christina Springer-Wanner, Hans Hoerauf, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
June 10, 2017
[Intraoperative Optical Coherence Tomography in Vitreoretinal Surgery: Clinical Experiences and Future Developments]
Mathias M Maier, Ali Nasseri, Carsten Framme, et al.
Current Eye Research
|
November 1, 2019
Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: <i>Post-hoc</i> Analysis from the COMRADE Trials
Amelie Pielen, Nicolas Feltgen, Lars-Olof Hattenbach, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
December 16, 2014
Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Albert J Augustin, Frank G Holz, Christos Haritoglou, et al.
Investigative Ophthalmology & Visual Science
|
February 3, 2018
Sphingosine Kinase 2 Modulates Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy
Jeanette Eresch, Martin Stumpf, Alexander Koch, et al.
Acta Ophthalmologica
|
June 2, 2018
Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study
Nicolas Feltgen, Lars-Olof Hattenbach, Thomas Bertelmann, et al.
Acta Ophthalmologica
|
March 3, 2017
Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B)
Lars-Olof Hattenbach, Nicolas Feltgen, Thomas Bertelmann, et al.
American Journal of Ophthalmology
|
July 13, 2016
Reply
Hans Hoerauf, Nicolas Feltgen, Claudia Weiss, et al.
Page
of 9